ANALYSIS: Questions over Abano's Australian operations as sales slump continues

ANALYSIS: Questions over Abano's Australian operations as sales slump continues
Jenny Ruth
By Jenny Ruth July 31 (BusinessDesk) - Abano Healthcare continues to do it tough in Australia where, even though it’s the second-largest corporate player, it has less than 2 percent of the market. Its annual sales across the Tasman haven’t grown since 2012 and appear to be getting worse; a 1.6 percent fall in same-store sales in the nine months ended February turned into a 2.9 percent decline for the year ended May. Abano has acknowledged some of that rot is permanent because it wrote off $2.6 million in goodwill relating to four of it...

More Opinion

Unscrambling EGS investment in Trump's world
Finance

David Chaplin: Unscrambling EGS investment in Trump's world

The US rush from ESG investments labels is well under way.

Risk is a four-letter word in NZ
Economy

Dileepa Fonseka: Risk is a four-letter word in NZ

NZ was once a global leader. Then it got comfortable.

Dileepa Fonseka 03 Feb 2025
The rise of tech apps and wobbly share prices
Opinion

Simon Robertson: The rise of tech apps and wobbly share prices

Some app stocks are climbers, others not so much. 

Simon Robertson 01 Feb 2025
We need to unlock a 'Go' economy
Economy

Cameron Bagrie: We need to unlock a 'Go' economy

New Zealand is no longer a high-income OECD economy.

Cameron Bagrie 30 Jan 2025